nVerses Capital »

Keros Therapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $140k 13k 10.70

More positions owned by nVerses Capital

CenterPoint Energy (CNP)
Abbvie (ABBV)
Knight-swift Transn Hldgs In Cl A (KNX)
Wal-Mart Stores (WMT)
Target Corporation (TGT)
Peoples Ban (PEBO)
Delta Air Lines Com New (DAL)
Astrana Health Com New (ASTH)
SM Energy (SM)
American Superconductor Corp Shs New (AMSC)
Mirum Pharmaceuticals (MIRM)
Arthur J. Gallagher & Co. (AJG)
Wright Express (WEX)
Mosaic (MOS)
Marriott Vacations Wrldwde Cp (VAC)

View all positions for nVerses Capital

Top funds holding Keros Therapeutics

BlackRock
Nantahala Capital Management
AQR Capital Management
Vanguard Capital Management
OrbiMed Advisors
Federated Investors
Vanguard Portfolio Management
Mackenzie Financial
Madison Avenue Partners
Qube Research & Technologies
Jacobs Levy Equity Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors

View all funds holding Keros Therapeutics